Sorin Group S.p.A. Invests in Cardiosolutions, a Development-Stage Company Focused on Mitral Valve Technology

Published: Jul 10, 2012

AN--(BUSINESS WIRE)--Sorin Group (MIL:SRN)(Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today a minority investment in Cardiosolutions Inc., an early-stage company focused on the development of an innovative percutaneous system to treat patients with moderate to severe mitral valve regurgitation.

Back to news